Patents
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
05/2003
05/20/2003US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis
05/15/2003US20030092687 5,6-Trans-2-alkylvitamin d derivatives
05/14/2003EP1310484A1 1-methyl-20-epivitamin d derivative
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/06/2003US6559138 For treatment of osteoporosis, the most common form of metabolic bone disease and may be considered the symptomatic, fracture stage of bone loss
05/02/2003EP1305030A1 USE OF 2$g(a)-METHYL-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP1015423B1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
05/01/2003WO2003035612A1 Polyethoxylated cholecalciferol derivatives and its preparation
05/01/2003US20030083319 For treating osteoporosis, secondary hyperparathyroidism, cancer and autoimmune diseases without inducing hypercalciuria, hypercalcemia, or nephrotoxicity
04/2003
04/29/2003US6555699 16-ENE-vitamin D derivatives
04/17/2003WO2003031455A1 Optically active dihydroxycyclohexane compounds and process for producing optically active hydroxyethylenedihydroxycycohexane compound
04/17/2003WO2003031402A1 Process for preparation of 19-norvitamin d derivatives
04/17/2003WO2003031401A1 Process for preparation of 19-norvitamin d derivatives
04/17/2003WO2003031400A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3
04/17/2003US20030073857 26,27-Homologated-20-epi-2-alkyl-19-nor-vitamin D compounds
04/16/2003EP1301479A2 STABILIZED 1$g(a)-HYDROXY VITAMIN D
04/16/2003EP1301189A2 USE OF 2-METHYLENE-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D 3? TO INCREASE BONE STRENGTH
04/15/2003US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine
04/15/2003US6548489 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
04/09/2003EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
04/08/2003US6544969 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds
04/08/2003CA2065849C Vitamin d analogues
04/03/2003WO2003027065A1 3-desoxy-vitamin d3 analog esters
04/03/2003CA2459789A1 3-desoxy-vitamin d3 analog esters
03/2003
03/26/2003EP1295871A1 Vitamin d derivatives
03/26/2003CN1103755C Novel structural analogues of vitamin D
03/25/2003US6538145 Having a hydroxy group at 24-position and, optionally, a substituent at 2 beta position; reacting intermediates of the A ring part and intermediates of the C ring; cyclization; coupling; control of calcium metabolism; antitumor agents
03/25/2003US6537982 Method of treating prostatic diseases using active vitamin D analogues
03/25/2003US6537981 26,27-Homologated-20-EPI-2-alklidene-19-nor-vitamin D compounds
03/25/2003US6537980 Vitamin D analogues and their pharmaceutical use
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/11/2003US6531460 Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same
03/11/2003US6531459 Vitamin D derivatives with phosphorus atoms in the side chains
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003US20030045509 Hydroxyvitamin D characterized by a purity equal to or greater than 98% by a weight-based HPLC assay, residual solvents of 0.5% or less, a total impurity of 1. 5% or less, and no single impurity of greater than 0.5%.
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
02/2003
02/27/2003WO2002017911A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives
02/27/2003US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation
02/27/2003CA2420759A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives
02/19/2003EP1284259A1 5,6- i TRANS /i -2-ALKYLVITAMIN D DERIVATIVES
02/19/2003CN1398254A Vitamin D derivatives having substituents at 2 alpha position
02/12/2003CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives
02/12/2003CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health
02/11/2003CA2125476C 20-methyl-substituted vitamin d derivatives
02/11/2003CA2041135C Method for the photochemical isomerisation of organic compounds under the influence of a photosensitizer
02/04/2003US6516294 Generating three-dimensional computer model
01/2003
01/30/2003US20030022872 Possesses excellent binding property to vitamin D receptors; for treating diseases accompanied by abnormal calcium metabolism
01/29/2003CN1394206A Novel vitamin D analogues
01/23/2003US20030018206 Crystals of a vitamin D derivative and a method for the preparation thereof
01/23/2003US20030018194 New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents
01/16/2003US20030013691 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
01/15/2003EP1275643A1 Vitamin d derivatives
01/15/2003EP1274680A1 Synthesis intermediate products for producing vitamin d derivatives
01/14/2003US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation
01/09/2003US20030009042 Method for making hydroxy-25-ene-vitamin D compounds
01/02/2003US20030004144 Anticancer agents; skin disorders
01/02/2003EP1270556A1 Intermediates for vitamin d and processes for the preparation thereof
01/02/2003EP1268416A1 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses
01/02/2003EP1268415A1 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
01/02/2003EP1268096A1 Extrusion die
12/2002
12/19/2002US20020193616 16-ene-vitamin d derivatives
12/18/2002EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
12/18/2002EP0957088B1 Vitamin d3 derivatives and process for producing the same
12/12/2002US20020188142 17-Side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
12/11/2002EP1056716B1 Cyclohexanediole derivatives
12/10/2002US6492353 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs
12/05/2002US20020183289 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses
12/05/2002US20020183288 Administering to a subject suffering from hyperparathyroidism an amount of active vitamin D formula sufficient to lower or maintain lowered blood parathyroid hormone (PTH) levels
11/2002
11/28/2002WO2002094754A1 Vitamin d analogues
11/27/2002EP1260502A1 Vitamin d derivatives having substituents at the 2alpha-position
11/26/2002CA2078555C Novel vitamin d analogues
11/19/2002US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/13/2002EP1255732A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
11/13/2002CN1379675A 24-hydroxyvitamin D, analogs and use thereof
11/12/2002US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/06/2002EP1254111A1 Novel vitamin d analogues
11/06/2002CN1093852C 维生素d酰胺衍生物 Amide derivatives of vitamin d
10/2002
10/30/2002EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health
10/29/2002CA2107471C Fluorine-containing vitamin d3 analogues
10/17/2002US20020151528 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
10/08/2002US6462031 Boiling ethyl formate, ethyl actate, and/or 2-propanol-hexane mixture as solvent under inert atmosphere, precipitating crystals with cooling
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
09/2002
09/24/2002US6455714 Labeled vitamin D compounds and the use thereof
09/24/2002CA2076772C Novel vitamin d3 analogues
09/19/2002US20020132799 Vitamin D3 dervative and treating agent for inflammatory respiratory disease using same
09/18/2002EP1240137A1 Method for making 24(s)-hydroxyvitamin d 2
09/18/2002EP1240136A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease
09/17/2002US6452028 Vitamin D3 analogs
09/12/2002US20020128241 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
09/11/2002EP0970047B1 2-alkylidene-19-nor-vitamin d compounds
09/10/2002US6448421 Purifying a crude product derivative through a reverse phase chromatography and then crystallizing from an organic solvent; oxy gonane and indene, cyclohexyl derivatives
09/05/2002US20020123638 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds
09/04/2002EP1235832A1 Vitamin d prescursors, method and intermediates
09/04/2002CN1090180C Vitamin D3 derivatives and remedies for infammatory respiratory disease
09/03/2002CA2118122C Isolation of steroids containing a 5,7-diene functionality from a sterol mixture
08/2002
08/29/2002WO2002066424A1 Vitamin d derivative having substituent in 2-position
08/28/2002EP1233942A2 Treatment of inflammatory bowel disease with vitamin d compounds
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 35